Legal & General Group’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.3K | Hold |
295
| – | – | ﹤0.01% | 2992 |
|
|
2025
Q4 | $16.5K | Hold |
295
| – | – | ﹤0.01% | 3103 |
|
|
2025
Q3 | $18.6K | Hold |
295
| – | – | ﹤0.01% | 3071 |
|
|
2025
Q2 | $16.8K | Hold |
295
| – | – | ﹤0.01% | 3086 |
|
|
2025
Q1 | $16.5K | Hold |
295
| – | – | ﹤0.01% | 3015 |
|
|
2024
Q4 | $18.1K | Hold |
295
| – | – | ﹤0.01% | 3058 |
|
|
2024
Q3 | $19.7K | Hold |
295
| – | – | ﹤0.01% | 3055 |
|
|
2024
Q2 | $19.7K | Sell |
295
-320
| -52% | -$21.8K | ﹤0.01% | 3021 |
|
|
2024
Q1 | $43.7K | Hold |
615
| – | – | ﹤0.01% | 2793 |
|
|
2023
Q4 | $51.8K | Buy |
615
+142
| +30% | +$11.8K | ﹤0.01% | 2802 |
|
|
2023
Q3 | $40.7K | Sell |
473
-35
| -7% | -$3.23K | ﹤0.01% | 2891 |
|
|
2023
Q2 | $47.3K | Hold |
508
| – | – | ﹤0.01% | 2882 |
|
|
2023
Q1 | $48.1K | Hold |
508
| – | – | ﹤0.01% | 2885 |
|
|
2022
Q4 | $51.1K | Hold |
508
| – | – | ﹤0.01% | 2946 |
|
|
2022
Q3 | $44K | Buy |
508
+54
| +12% | +$4.77K | ﹤0.01% | 3005 |
|
|
2022
Q2 | $39K | Buy |
454
+80
| +21% | +$6.82K | ﹤0.01% | 3046 |
|
|
2022
Q1 | $34K | Hold |
374
| – | – | ﹤0.01% | 3084 |
|
|
2021
Q4 | $38K | Hold |
374
| – | – | ﹤0.01% | 3091 |
|
|
2021
Q3 | $34K | Hold |
374
| – | – | ﹤0.01% | 3086 |
|
|
2021
Q2 | $32K | Sell |
374
-79
| -17% | -$6.83K | ﹤0.01% | 3117 |
|
|
2021
Q1 | $40K | Sell |
453
-584
| -56% | -$51.4K | ﹤0.01% | 2896 |
|
|
2020
Q4 | $88K | Hold |
1,037
| – | – | ﹤0.01% | 2622 |
|
|
2020
Q3 | $83K | Sell |
1,037
-141
| -12% | -$11.7K | ﹤0.01% | 2539 |
|
|
2020
Q2 | $105K | Hold |
1,178
| – | – | ﹤0.01% | 2514 |
|
|
2020
Q1 | $108K | Sell |
1,178
-158
| -12% | -$14.7K | ﹤0.01% | 2388 |
|
|
2019
Q4 | $144K | Buy |
1,336
+116
| +10% | +$11.8K | ﹤0.01% | 2482 |
|
|
2019
Q3 | $117K | Buy |
1,220
+651
| +114% | +$60.5K | ﹤0.01% | 2479 |
|
|
2019
Q2 | $54K | Hold |
569
| – | – | ﹤0.01% | 2749 |
|
|
2019
Q1 | $50K | Hold |
569
| – | – | ﹤0.01% | 2708 |
|
|
2018
Q4 | $47K | Buy |
569
+76
| +15% | +$6.69K | ﹤0.01% | 2721 |
|
|
2018
Q3 | $46K | Hold |
493
| – | – | ﹤0.01% | 2814 |
|
|
2018
Q2 | $54K | Sell |
493
-85
| -15% | -$8.88K | ﹤0.01% | 2714 |
|
|
2018
Q1 | $57K | Sell |
578
-342
| -37% | -$30.5K | ﹤0.01% | 2690 |
|
|
2017
Q4 | $74K | Sell |
920
-111
| -11% | -$8.67K | ﹤0.01% | 2722 |
|
|
2017
Q3 | $76K | Buy |
1,031
+195
| +23% | +$14K | ﹤0.01% | 2769 |
|
|
2017
Q2 | $61K | Hold |
836
| – | – | ﹤0.01% | 2852 |
|
|
2017
Q1 | $52K | Sell |
836
-115
| -12% | -$7.24K | ﹤0.01% | 2856 |
|
|
2016
Q4 | $68K | Buy |
951
+353
| +59% | +$22.9K | ﹤0.01% | 2774 |
|
|
2016
Q3 | $37K | Hold |
598
| – | – | ﹤0.01% | 2659 |
|
|
2016
Q2 | $38K | Buy |
+598
| New | +$38.6K | ﹤0.01% | 2611 |
|
Other funds holding UTMD
BIP
VCM
MA
RHJA
Legal & General Group's UTMD Position: Q1 2026 in Review
Legal & General Group held its Utah Medical Products (UTMD) position steady in Q1 2026 at 295 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2992.
Legal & General Group first reported a position in UTMD in Q2 2016 and has held it in 40 quarters since. The position peaked at $144K in Q4 2019. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.
- Legal & General Group held 295 shares of Utah Medical Products worth $18.3K as of Q1 2026.
- Legal & General Group left its Utah Medical Products share count unchanged in Q1 2026.
- Utah Medical Products made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2992 holding.
- Legal & General Group first reported a position in Utah Medical Products in Q2 2016 and has held it in 40 quarters since.
- Legal & General Group's Utah Medical Products position peaked at $144K in Q4 2019.
- 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.